Email Us Here

Crossbeta Biosciences Completes Financing Round and Appoints Guus Scheefhals as CEO

Today, Crossbeta Biosciences announced that it has successfully completed a financing round of up to EUR2 million and appointed Guus Scheefhals as Chief Executive Officer.